Job Search Results - BioSpace
Get Our FREE Industry eNewsletter


Refine Job Search:

Clear All Selections
Selected Employer
AbbVie Stemcentrx
Location (7)
Employers (7)
Area of Expertise (0)
Posted Date (7)
Position Type (7)
Required Education (7)

Clear All Selections

Your search returned 7 jobs



9/13/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

9/11/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

9/11/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

9/6/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a keytherapeutic area for AbbVie, with a portfolio consisting of three marketedproducts — Imbruvica, Venclexta, and Empliciti — and a pipeline containingmultiple promising new molecules that are being studied in nearly 200...

8/31/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

8/31/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

8/24/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...